VeinWay Closes Oversubscribed SAFE Round and Begins Series A Round
Vascular Surgeons Stephen Black, MD, and Houman Jalaie, MD, PhD join VeinWay’s Scientific Advisory Board.
OR YEHUDA, Israel, Sept. 7, 2023 /PRNewswire/ — VeinWay has closed an oversubscribed SAFE round of investment and has opened a series A round.
The funds will be used to complete all design verification testing and to prepare for VeinWay’s First-in-Human clinical trial of its Traversa system towards an FDA IDE trial planned for the first half of 2024.
